Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
amphetamines
anxiety
anxiolytic agents
benzodiazepine
butorphenol
detoxification
dizziness
drug abuse
drug addiction
drug dependence
drug induced neurologic disorders
drug withdrawal
ergotamine
headache
headache, chronic
headache, chronic daily
headache, drug induced
headache, rebound
headache, treatment of
intranasal medication
migraine
migraine, treatment of
narcotic analgesics
nasal spray
opiate
panic attacks
review article
sedation
severity of dependence scale
somnolence
stimulant drugs
sumatriptan
treatment of neurologic disorder
Showing articles 50 to 100 of 6670 << Previous Next >>

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
NEJM 391:1015-1027, Al-Samkari,H.,et al, 2024

Progressive Cervical Osteophytosis and Dysphagia Associated with Isotretinoin Treatment for Rosacea
Lancet 404:e4, Naraghi,K. & Marzo-Ortega,H., 2024

Intravenous Thrombolysis in Patients with Cervical Artery Dissection
Neurol 103:e209843, Shu,L.,et al, 2024

CSF and Plasma Biomarkers in Patients with Iatrogenic Cerebral Amyloid Angiopathy
Neurol 103:e209828, Pollaci,G.,et al, 2024

Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024

A 32-Year-Old Man with Painless Bilateral Shoulder Girdle Weakness and Atrophy
Neurol 103:e209915, Gutti,N.B.,et al, 2024

An Unusual Etiology of Lumbosacral Plexopathy in a Patient with HIV
Neurol 103:e209930, Madduluri,B.,et al, 2024

Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source
Neurol 103:e209949, Grannam,M.,et al, 2024

Lentiviral Gene Therapy for Cerebral adrenoleukodystrophy
NEJM 391:1302-1312,1358, Eichler,F.,et al, 2024

Forensic Neurology:Practice Considerations and Training Opportunities
Neurol 103:e209560, Zheng,D.,et al, 2024

Clinicopathologic Conference, Brain Abscess Due to Infection with Listeria Monocytogeneses
NEJM 391:1529-1538, Case 33-2024, 2024

Acute Postradiation Lumbosacral Plexopathy
Neurol 103:e209972, Koropouli,E.,et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024

Intramedullary Spinal Cord Abscess Caused by Acupuncture
Ann Neurol 96:1026-1027, Liu,J.,et al, 2024

Clinical Features, Diagnosis and Management of Klinefelter Syndrome
www.UptoDaate.com, Matsumoto,A.M. & Anawals,B.D., 2024

Risk of Stroke and Myocardial Infarction Among Initiators of Triptans
JAMA Neurol 81:248-254, Petersen,C.L.,et al, 2024

Association of Assisted Reproductive Technology and Stroke During Hospitalization for Delivery in the United States
Stroke 55:999-1005, Dicpinigaitis,A.J.,et al, 2024

Transcarotid Arter Revascularization Expanding Our Arsenal for the Management of Symptomatic Carotid Artery Stenosis
Stroke 55:931-933, Palaiodimou,L, 2024

Rabbit Syndrome
Neurol102:e209275, Huynh,T.U., & Beckley, E.H., 2024

Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024

Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024

Cavernous Maliformations of the Central Nervous System
NEJM 390:1022-1028, Smith,E.R., 2024

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
JAMA Neurol 8:363-372, Sheth,K.M.,et al, 2024

Immunosuppressive Therapy Reversing Obstructive Hydrocephalus in CLIPPERS
Neurol 102:e209396, Yang,Y.,et al, 2024

Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Stroke 55:1416-1427, Tartarin,H.,et al, 2024

Treatment Modalities and Outcomes in Brainstem Cavernous Malformations: A Large Multicenter Observational Cohort Study
Stroke 55:1151-1160, Lu,J.,et al, 2024

Herpes Simplex Virus Encephalitis in Patients with Autoimmune Conditions or Exposure to Immunomodulatory Medications
Neurol 102:e209297, Tang,A.,et al, 2024

Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
NEJM 390:1677-1689, Costalat,V.,et al, 2024

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
NEJM 390:1745-1755, 1815, Connolly,S.J.,et al, 2024

Mechanical Thrombectomy in Anticoagulated Patients with Acute Ischemic Stroke, A Meta-Analysis
Neurologist 29:194-203, Zhang,H.L.,et al, 2024

Tenecteplase Versus Standard of Care for Minor Ischaemic Stroke with Proven Occlusion (TEMPO-2): A Randomised, Open Label, Phase 3 Superiority Trial
Lancet 403:2597-2605, Coutts,S.B.,et al, 2024

Leptomeningitis with Communicating Hydrocephalus in an Immunocompromised Patient with Disseminated Sporotrichosis
Neurol 103:e209586, Taborda,M.H.,et al, 2024

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated with Attendance
JAMA Neurol 81:732-740, Li,Y., et al, 2024

Incidence and Types of Cardiac Arrhythmias in the Pei-Ictal Period in Patients Having a Generalized Convulsive Seizure
Neurol 103; e209501, Vilella,L.,et al, 2024

Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hour
NEJM 391:273-275, Lee,V.H., 2024

Advances in Cerebral Venous Thrombosis
Stroke 55:2169-2172, deSousa,D.A. & Neto,L.L., 2024

Angioedema Following Tenecteplase for Acute Ischemic Stroke
Stroke 55:e242-e244, Dellabella,A.,et al, 2024

Angioedema After Use of Recombinant Tissue-Type Plasminogen Activators in Stroke
Stroke 55:2193-2197, Hutten,E., 2024

Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024

A Rare Neurotoxicity Syndrome Following Opioid Intoxication
Ann Neurol 96:412-415, Venkatraman,S.,et al, 2024

Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients with ICH and Mechanical Heart Valves
Neurol 103:e209664, Sakusic,A.,et al, 2024

Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024

Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024

Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
NEJM 390:522-529, Strong, N.,et al, 2024

Ischemic Retinopathy from Prolonged Orbital Compression
NEJM 390::e14, Chen,Y-K and Chen C-L, 2024

A 54-Year-Old Woman with Progressive Headache and Neurologic Decline
Neurol 102:e209190, Cheng,Y. & Zachariah,J., 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024



Showing articles 50 to 100 of 6670 << Previous Next >>